# Neilmed Pharmaceuticals Inc – FDA 483, Jul 22, 2026

Source: https://www.keypedia.com/records/483/neilmed-pharmaceuticals-inc/38577949-5487-4133-84de-97933859eae0

> FDA 483 for Neilmed Pharmaceuticals Inc on July 22, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Neilmed Pharmaceuticals Inc
- Inspection Date: 2026-07-22
- Product Type: drugs
- Office Name: San Francisco District Office
- Summary: Neilmed Pharmaceuticals Inc. received a Form 483 citing multiple deficiencies across its quality control, training, equipment cleaning, calibration, material specifications, and warehousing operations. Issues included inadequate laboratory record control, unreviewed contract testing reports, insufficient employee competence verification, rusty equipment use, and unsecured labeling storage, indicating a systemic lack of adherence to established procedures and GMP requirements.

## Related Documents

- [483 - 2022-12-02](https://www.keypedia.com/records/483/neilmed-pharmaceuticals-inc/9d5ee954-9116-4e0f-8ba7-7ca4eb469a45) — date: December 2, 2022

## Related Officers

- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/neilmed-pharmaceuticals-inc/3900fd37-ad3b-4497-a182-db1d1b74f443

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df